PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM FILES FIRST IND WITH US FDA, page-13

  1. 951 Posts.
    lightbulb Created with Sketch. 196
    But for that to happen first we need the IND approval........... Hopefully PAR will get the approval by sep and they can start the course with the agreed patients....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.